Strateos
PrivateLast Round
Series B
Jun 8, 2021
Est. Valuation
$200M
Total Funding Raised
$119.76M
Company Overview
Strateos is a biotechnology company that offers a robotic cloud lab platform to streamline and enhance drug discovery and synthetic biology research.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Platform-as-a-Service, Industrial Robotics
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting, Subscription SaaS
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Strateos Comparables
Compare Strateos with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Emerald Cloud Lab | 88% | |
| Arctoris | 82% | |
| Synthace | 73% |
Strateos Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jun 8, 2021 | ||||
| Grant | Sep 15, 2019 | ||||
| Corporate Funding | Jun 3, 2019 | ||||
| Grant | Apr 12, 2018 | ||||
| Series A Extension | Nov 17, 2016 | ||||
Series B | Jul 11, 2016 |
Strateos Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Dolby Family Ventures | Series A, Corporate Funding, Series B |
| GV | Seed |
| U.S. Department of Health and Human Services | Grant |
| Comet Labs | Series B |
| MITS Capital | Series A |
| Thiel Foundation | Grant |
| Ally Bridge Group | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Monthly visitors grew 235% MoM, reaching 2.5K.
- Jun 3, 2019
Raised $17M led by Lux Capital and DCVC.
Strateos Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Strateos's valuation, stock price, and market status.
Is Strateos a public or private company?
Strateos is a private company.
What is the current stock price of Strateos?
Strateos is a private company with no public stock price. No recent secondary market data is available.
How much is Strateos worth (valuation)?
Strateos's valuation is estimated at $200.0M based on funding round data.
Can I buy Strateos stock?
Strateos shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Strateos's last funding round?
Strateos's most recent funding round was Series B on June 8, 2021.
Who are the main investors in Strateos?
Key investors in Strateos include GV, Lux Capital, IA Ventures, DCVC (Data Collective).
Will Strateos IPO soon?
No public IPO plans have been announced for Strateos.
How can I track Strateos secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Strateos's secondary market activity and sign up for updates.